Long-term follow-up study of hypertensive patients by practicing internists after a controlled drug trial.

Détails

ID Serval
serval:BIB_3D7537013274
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Long-term follow-up study of hypertensive patients by practicing internists after a controlled drug trial.
Périodique
Clinical therapeutics
Auteur⸱e⸱s
Waeber B., Avigdor L., Brunner H.R.
ISSN
0149-2918 (Print)
ISSN-L
0149-2918
Statut éditorial
Publié
Date de publication
1984
Peer-reviewed
Oui
Volume
6
Numéro
4
Pages
509-517
Langue
anglais
Notes
Publication types: Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
Thirty patients with uncomplicated essential hypertension were treated for an average of 44 months by 14 internists in private practice. All patients had previously participated in a controlled comparative trial of antihypertensive drugs carried out by the same physicians in their offices. During the long-term follow-up period, ie, after completion of the initial trial, the physicians administered antihypertensive therapy based on their best judgment; the drugs they most commonly prescribed were diuretics (80% of patients) and beta-blocking agents (60% of patients). Although 80% of the patients received at least two different antihypertensive agents, diastolic pressures fell below 96 mmHg in approximately 60% of the patients and below 90 mmHg in only a small fraction. Thus it appears that it is not easy for physicians in private practice to optimally reduce blood pressure levels in hypertensive patients despite the availability of numerous antihypertensive drugs. The tendency of practitioners to approximate blood pressure levels to multiples of 5 or even 10 mmHg may be partially responsible for the unsatisfactory results.
Mots-clé
Antihypertensive Agents/therapeutic use, Blood Pressure/drug effects, Debrisoquin/therapeutic use, Double-Blind Method, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Hypertension/drug therapy, Long-Term Care, Male, Mefruside/therapeutic use, Methyldopa/therapeutic use, Middle Aged, Propranolol/therapeutic use
Pubmed
Web of science
Création de la notice
04/03/2009 16:04
Dernière modification de la notice
23/02/2024 14:34
Données d'usage